Digital Knowledge Repository of Central Drug Research Institute, Lucknow (India) >
Publications of CDRI Scientists >
Microbiology >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/507
|
| Title: | New Antimalarial Drug Development in India: Radical Curative Agents CIDRI 80/53 (Elubaquine) and WR 238605 (Tafenoquine) |
| Authors: | Dutta, G P
Puri, S K |
| Keywords: | Malaria
Anti-relapse drugs
CDRI 80/53/Bulaquine/Elubagttine
WR 238605/ Tafenoquine
Antimalarials
Plasmodium
Gametocytocide
Aablaquin |
| Issue Date: | 2003 |
| Citation: | Proc Indian National Science Academy -2003-B69 No.6 871-882 |
| Abstract: | Global efforts had been continued for the last 50) years, to find a safe radical curative (anti-relapse) drug to replace primaquine for the treatment of Plasomodium vivax and P. ovale, Throughout the world, more than 250 potential tissue. schizontocides had been synthesized and screened, and two new primaquine derivatives had been identified in primate malaria radical curative tests which could be the candidate drugs to replace primaquine: |
| URI: | http://hdl.handle.net/123456789/507 |
| Appears in Collections: | Microbiology
|
Files in This Item:
| File |
Description |
Size | Format |
|---|
| procindiannatnsciacadB69-6-871-882-2003.pdf | | 6117Kb | Adobe PDF | View/Open |
|
All items in DSpace are protected by copyright, with all rights reserved.
|
